SEI Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
44,932
+7,404
| +20% | +$409K | ﹤0.01% | 1563 |
|
|
2025
Q1 | $1.81M | Buy |
37,528
+12,960
| +53% | +$627K | ﹤0.01% | 1676 |
|
|
2024
Q4 | $948K | Sell |
24,568
-10,510
| -30% | -$406K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $1.58M | Sell |
35,078
-6,685
| -16% | -$301K | ﹤0.01% | 1784 |
|
|
2024
Q2 | $1.45M | Buy |
41,763
+5
| +0% | +$173 | ﹤0.01% | 1770 |
|
|
2024
Q1 | $1.21M | Buy |
41,758
+4,529
| +12% | +$131K | ﹤0.01% | 1809 |
|
|
2023
Q4 | $854K | Sell |
37,229
-2,987
| -7% | -$68.5K | ﹤0.01% | 1927 |
|
|
2023
Q3 | $671K | Sell |
40,216
-31,800
| -44% | -$530K | ﹤0.01% | 2011 |
|
|
2023
Q2 | $1.99M | Buy |
72,016
+36,377
| +102% | +$1M | ﹤0.01% | 1634 |
|
|
2023
Q1 | $820K | Sell |
35,639
-306
| -0.9% | -$7.04K | ﹤0.01% | 1951 |
|
|
2022
Q4 | $392K | Sell |
35,945
-617
| -2% | -$6.73K | ﹤0.01% | 2117 |
|
|
2022
Q3 | $308K | Sell |
36,562
-84,443
| -70% | -$711K | ﹤0.01% | 2292 |
|
|
2022
Q2 | $957K | Sell |
121,005
-9,713
| -7% | -$76.8K | ﹤0.01% | 1851 |
|
|
2022
Q1 | $3.1M | Sell |
130,718
-1,595
| -1% | -$37.8K | 0.01% | 1353 |
|
|
2021
Q4 | $4.53M | Buy |
132,313
+86,138
| +187% | +$2.95M | 0.01% | 1187 |
|
|
2021
Q3 | $818K | Sell |
46,175
-60,359
| -57% | -$1.07M | ﹤0.01% | 1867 |
|
|
2021
Q2 | $4.78M | Buy |
106,534
+19,654
| +23% | +$882K | 0.01% | 1103 |
|
|
2021
Q1 | $2.25M | Buy |
+86,880
| New | +$2.25M | 0.01% | 1399 |
|